| NCT Number | NCT05510934 |
| Lead Sponsor | Nova Scotia Health Authority |
| Conditions | Low Risk Differentiated Thyroid Cancer |
| Enrollment | 60 participants |
| Start Date | 2022-09-30 |
| Primary Completion | 2025-09-30 (estimated) |
| Study Completion | 2025-12-30 (estimated) |
| Updated on ClinicalTrials.gov | 2024-08-21 |